tradingkey.logo

SelectQuote Inc

SLQT
1.840USD
-0.080-4.17%
Cierre 10/17, 16:00ETCotizaciones retrasadas 15 min
317.98MCap. mercado
12.70P/E TTM

SelectQuote Inc

1.840
-0.080-4.17%

Más Datos de SelectQuote Inc Compañía

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

Información de SelectQuote Inc

Símbolo de cotizaciónSLQT
Nombre de la empresaSelectQuote Inc
Fecha de salida a bolsaMay 21, 2020
Director ejecutivoMr. Timothy Robert (Tim) Danker
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 21
Dirección6800 West 115Th Street
CiudadOVERLAND PARK
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal66211
Teléfono19132741994
Sitio Webhttps://ir.selectquote.com/investor-home/default.aspx
Símbolo de cotizaciónSLQT
Fecha de salida a bolsaMay 21, 2020
Director ejecutivoMr. Timothy Robert (Tim) Danker

Ejecutivos de SelectQuote Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
318.58K
--
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
310.58K
--
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Mr. Sloan Bohlen
Mr. Sloan Bohlen
Investor Relations
Investor Relations
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Stephanie D. Fisher
Ms. Stephanie D. Fisher
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
318.58K
--
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
310.58K
--
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy revenue
728.75M
47.74%
Commission
696.26M
45.61%
Production bonus and other revenue
101.58M
6.65%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy revenue
728.75M
47.74%
Commission
696.26M
45.61%
Production bonus and other revenue
101.58M
6.65%

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Brookside Equity Partners LLC
10.05%
BlackRock Institutional Trust Company, N.A.
5.23%
The Vanguard Group, Inc.
4.67%
Abrams Bison Investments, L.L.C.
4.50%
Mariner Wealth Advisors
3.62%
Otro
71.93%
Accionistas
Accionistas
Proporción
Brookside Equity Partners LLC
10.05%
BlackRock Institutional Trust Company, N.A.
5.23%
The Vanguard Group, Inc.
4.67%
Abrams Bison Investments, L.L.C.
4.50%
Mariner Wealth Advisors
3.62%
Otro
71.93%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
20.45%
Investment Advisor/Hedge Fund
14.25%
Individual Investor
11.31%
Private Equity
10.05%
Hedge Fund
6.71%
Research Firm
1.75%
Corporation
0.62%
Pension Fund
0.44%
Bank and Trust
0.38%
Otro
34.04%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
323
95.31M
54.19%
+27.38K
2025Q2
332
110.44M
63.96%
+4.81M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Brookside Equity Partners LLC
17.68M
10.05%
--
--
Sep 20, 2025
BlackRock Institutional Trust Company, N.A.
9.21M
5.23%
-284.53K
-3.00%
Jun 30, 2025
The Vanguard Group, Inc.
8.21M
4.67%
+360.95K
+4.60%
Jun 30, 2025
Abrams Bison Investments, L.L.C.
7.91M
4.5%
--
--
Jun 30, 2025
Mariner Wealth Advisors
6.37M
3.62%
+79.16K
+1.26%
Jun 30, 2025
Grant (William Thomas II)
4.66M
2.65%
+94.89K
+2.08%
Nov 12, 2024
Grant (Robert Clay)
4.32M
2.45%
--
--
Sep 20, 2025
Grant (William Thomas III)
4.20M
2.39%
--
--
Sep 20, 2025
Geode Capital Management, L.L.C.
3.30M
1.88%
+129.93K
+4.10%
Jun 30, 2025
State Street Investment Management (US)
3.10M
1.76%
+13.17K
+0.43%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
iShares Micro-Cap ETF
0.06%
WisdomTree US SmallCap Quality Growth Fund
0.05%
Fidelity Enhanced Small Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Avantis US Small Cap Value ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Ver más
iShares Micro-Cap ETF
Proporción0.06%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.05%
Fidelity Enhanced Small Cap ETF
Proporción0.04%
Avantis US Small Cap Equity ETF
Proporción0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.02%
ProShares Hedge Replication ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Avantis US Small Cap Value ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI